Back to top

genetics: Archive

Kevin Cook

Bear of the Day: CRISPR Therapeutics (CRSP)

Gene editors got a big boost recently from sickle cell potential and Cathie Wood's thematic investing

CRSPNegative Net Change EDITNegative Net Change ARKKNegative Net Change NTLANegative Net Change ARKGNegative Net Change

Kevin Cook

Bear of the Day: Illumina (ILMN)

Maker of premier next-gen genomic sequencing technology lowers guidance but shares make new highs

ILMNNegative Net Change EDITNegative Net Change NVTANegative Net Change ARKKNegative Net Change ARKGNegative Net Change

Sweta Jaiswal, FRM

5 Top-Performing ARK ETFs Worth Your Attention Now

Here we highlight some ETFs from the house of ARK Investment Management that have gained more than 100% in the past year for our investors to consider.

TDOCNegative Net Change PYPLNegative Net Change SQNegative Net Change ARKQNegative Net Change ARKWNegative Net Change ARKKNegative Net Change CRSPNegative Net Change ROKUNegative Net Change ARKGNegative Net Change GBTCNegative Net Change ARKFNegative Net Change

Kevin Cook

Bull of the Day: Meridian Bioscience (VIVO)

Small-cap diagnostics player will grow sales 20%+ to over $310 million on COVID-19 testing and its mutations

VIVONegative Net Change HOLXNegative Net Change QDELNegative Net Change EDITNegative Net Change CRSPNegative Net Change

Daniel Laboe

The Innovative Future Of ETFs

Ark Invest is driving a new generation of actively managed ETFs

TSLANegative Net Change SQNegative Net Change ROKUNegative Net Change PRLBNegative Net Change NVTANegative Net Change CRSPNegative Net Change ARKKNegative Net Change

Sweta Jaiswal, FRM

Genomics ETFs Surge on Nobel Prize for Gene-Editing Pioneers

The announcement of the 2020 Nobel Prize winners for Chemistry has successfully brought investor attention to the gene-editing space.

PBENegative Net Change ARKGNegative Net Change GNOMNegative Net Change IDNANegative Net Change

Madeleine Johnson

Bear of the Day: Illumina (ILMN)

The coronavirus pandemic has dampened this medical stock's earnings and outlook.

TMONegative Net Change ILMNNegative Net Change

Kevin Cook

Bull of the Day: Quidel (QDEL)

Multiple FDA approvals for new 15-minute COVID-19 antigen tests have estimates and shares rising sharply

QDELNegative Net Change MRNAPositive Net Change

Sweta Jaiswal, FRM

Profit from the Genomics Market Momentum With These ETFs

Here we highlight some ETFs for gaining exposure to the genomics market that is currently buzzing with opportunities for investors to cash on.

GSKNegative Net Change PBENegative Net Change ARKGNegative Net Change GNOMNegative Net Change IDNANegative Net Change

Kevin Cook

Bull of the Day: Vertex Pharma (VRTX)

While COVID-19 interrupts clinical trials, the champ of cystic fibrosis is about to repeat another year of 37% revenue growth

VRTXNegative Net Change CRSPNegative Net Change